A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/445 (2006.01) A61K 31/43 (2006.01) A61K 31/454 (2006.01) A61K 31/522 (2006.01) A61K 31/545 (2006.01) A61K 31/557 (2006.01) A61K 31/56 (2006.01) A61K 38/18 (2006.01) A61K 38/21 (2006.01) A61K 38/27 (2006.01)
Patent
CA 2504024
Methods of treating, preventing and/or managing macular degeneration are disclosed. Specific embodiments encompass the administration of an immunomodulatory compound, or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer, clathrate, or prodrug thereof, alone or in combination with a second active agent and/or surgery. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.
L'invention concerne des méthodes de traitement, de prévention et/ou de gestion d'une dégénération maculaire. Des modes de réalisation spécifiques de l'invention consistent à administrer un composé immunomodulateur, ou un sel pharmaceutiquement acceptable, un solvate, un hydrate, un stéréoisomère, un clathrate, ou un promédicament de celui-ci, seul ou combiné à un second agent actif et/ou à une chirurgie. L'invention concerne des compositions pharmaceutiques, des formes dosifiées unitaires simples, et des trousses appropriées à une utilisation dans les méthodes de l'invention.
Celgene Corporation
Smart & Biggar
LandOfFree
Composition for the treatment of macular degeneration does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition for the treatment of macular degeneration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for the treatment of macular degeneration will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1577453